×

Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof

  • US 8,377,977 B2
  • Filed: 07/22/2009
  • Issued: 02/19/2013
  • Est. Priority Date: 08/13/2004
  • Status: Active Grant
First Claim
Patent Images

1. An extended release tablet formulation, wherein the tablet consists of pramipexole-dihydrochloride monohydrate, carbomer 941 as a water swelling polymer, lactose monohydrate, microcrystalline cellulose, colloidal silicon dioxide, and magnesium stearate, such that the pramipexole-dihydrochloride monohydrate is in a matrix of the water swelling polymer.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×